期刊
SCIENCE ADVANCES
卷 8, 期 9, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abj0112
关键词
-
资金
- CIHR [MOP 133611]
- Savoy Foundation
- Swiss National Science Foundation [31003A_159867, 310030_192522, 320030_179277]
- ERA-NET NEURON [32NE30_173678/1]
- Synapsis Foundation
- Vontobel foundation
- Internal UZH
- Forschungskredit Candoc
- Forschungskredit postdoc grant
- Swiss National Science Foundation (SNF) [320030_179277, 31003A_159867, 310030_192522] Funding Source: Swiss National Science Foundation (SNF)
This study investigates the role of microglia in synapse elimination after ischemia and identifies brain-derived neurotrophic factor (BDNF) as a key player in this process. The researchers found that microglia release BDNF to downregulate glutamatergic and GABAergic synapses in the peri-infarct area. They also discovered that microglia activation and gephyrin phosphorylation are involved in neuroplasticity after middle cerebral artery occlusion (MCAO). Deletion of the Bdnf gene in microglia or GphnS268A/S270A mutation protects against brain damage, neuroinflammation, and synapse downregulation after MCAO.
Microglia interact with neurons to facilitate synapse plasticity; however, signal(s) contributing to microglia activation for synapse elimination in pathology are not fully understood. Here, using in vitro organotypic hippocampal slice cultures and transient middle cerebral artery occlusion (MCAO) in genetically engineered mice in vivo, we report that at 24 hours after ischemia, microglia release brain-derived neurotrophic factor (BDNF) to downregulate glutamatergic and GABAergic synapses within the peri-infarct area. Analysis of the cornu ammonis 1 (CA1) in vitro shows that proBDNF and mBDNF downregulate glutamatergic dendritic spines and gephyrin scaffold stability through p75 neurotrophin receptor (p75(NTR)) and tropomyosin receptor kinase B (TrkB) receptors, respectively. After MCAO, we report that in the peri-infarct area and in the corresponding contralateral hemisphere, similar neuroplasticity occurs through microglia activation and gephyrin phosphorylation at serine-268 and serine-270 in vivo. Targeted deletion of the Bdnf gene in microglia or GphnS268A/S270A (phospho-null) point mutations protects against ischemic brain damage, neuroinflammation, and synapse downregulation after MCAO.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据